Plasma fibrinogen

Ann Clin Biochem 2004;41:430-440
doi:10.1258/0004563042466884
© 2004 Association for Clinical Biochemistry

 

This Article

Full Text (PDF)


Alert me when this article is cited

Alert me if a correction is posted
Services

Email this article to a friend

Similar articles in this journal


Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles
Citing Articles via Google Scholar
Google Scholar

Articles by Lowe, G. D.

Articles by Mackie, I. J
Search for Related Content
PubMed

PubMed Citation
Social Bookmarking

What’s this?

Review Articles


Gordon DO Lowe,
Ann Rumley and
Ian J Mackie


Department of Medicine, University of Glasgow Glasgow, Scotland, UK;
Department of Medicine University of Glasgow Glasgow, Scotland, UK;
Department of Haematology University College London Medical School London

Fibrinogen is the major plasma protein coagulation factor. Lowplasma fibrinogen concentrations are therefore associated withan increased risk of bleeding due to impaired primary and secondaryhaemostasis. Fibrinogen is a classical positive acute-phasereactant protein and is an independent predictor of coronaryheart disease events. This review considers available methodsfor measurement of fibrinogen and makes recommendations as totheir appropriate use.

Total clottable fibrinogen assays are the definitive and referencemethod for plasma fibrinogen measurement. However, they aretime-consuming and are rarely required in clinical practice.Clotting rate assays remain the routine method of choice forinvestigation, monitoring and treatment of bleeding disordersassociated with low plasma fibrinogen concentrations. They areappropriately sited in haematology or haemostasis laboratories,with facilities for further relevant investigations, and expertadvice from consultant haematologists on appropriate management.They have also been used in the majority of studies investigatingincreasing fibrinogen concentrations as a cardiovascular riskfactor. Prothrombin-time derived assays are widely used, becausethey are less expensive and come at no extra cost with prothrombintime assays. However, their results vary widely with analysersand reagents, show discrepancies with clotting rate assays forboth low and normal plasma fibrinogen samples, and at presentthey are not recommended by routine clinical use. Immunoassays(radial immunodiffusion, enzyme-linked immunosorbent assay ornephelometric) are useful in (a) differentiating hypofibrinogenaemiafrom dysfibrinogenaemia, and (b) assessing cardiovascular riskand acute-phase reactions. Unlike clottable fibrinogen assays,immunoassays can be performed in dipotassium edetate anticoagulatedsamples.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What’s this?